Cargando…
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
Cutaneous leishmaniasis exhibits a wide spectrum of clinical manifestations; however, only a limited number of drugs are available and include Glucantime(®) and amphotericin B, which induce unacceptable side effects in patients, limiting their use. Thus, there is an urgent demand to develop a treatm...
Autores principales: | de Lima, Sarah Kymberly Santos, Cavallone, Ítalo Novaes, Serrano, Dolores Remedios, Anaya, Brayan J., Lalatsa, Aikaterini, Laurenti, Márcia Dalastra, Lago, João Henrique Ghilardi, da Silva Souza, Dalete Christine, Marinsek, Gabriela Pustiglione, Lopes, Beatriz Soares, de Britto Mari, Renata, Passero, Luiz Felipe Domingues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675550/ https://www.ncbi.nlm.nih.gov/pubmed/38004580 http://dx.doi.org/10.3390/pharmaceutics15112602 |
Ejemplares similares
-
High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023) -
Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
por: de Jesus, Jéssica Adriana, et al.
Publicado: (2021) -
Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2019) -
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2021) -
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2020)